Browse by category

New survey reveals how surgeons define innovation in real life

A recent survey carried out by Sermo, a physician-only online community of more than 1.3 million healthcare providers globally,...

First subject receives DR10624 for the treatment of obesity and hypertriglyceridemia

Zhejiang Doer Biologics, a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

MEDICAL IP gains FDA approval for DeepCatch AI software for whole-body composition CT quantification

MEDICAL IP, an AI-based digital twin company, has revealed its CT-based automatic body composition analysis AI software, DeepCatch, has...

GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier

GI Dynamics, the creator of the EndoBarrier device designed to target the underlying cause of type 2 diabetes, has announced it has...

Phenomix Sciences launches MyPhenome Hungry Brain phenotype swab test

Phenomix Sciences has launched its second of its gut-brain axis phenotyping test, MyPhenome Hungry Brain, new buccal swab test that...

Positive results for mizagliflozin in post-bariatric hypoglyceamia patients

Vogenx has announced positive results from its VGX 001-011 study, a phase 2 multi-centre, randomised, sequential crossover, single...

Eiger BioPharmaceuticals to focus Avexitide for hyperinsulinemic hypoglycaemia indications

Eiger BioPharmaceuticals has revealed it will focus its development efforts on advancing avexitide in hyperinsulinemic hypoglycaemia...

NICE needs more evidence before recommending tirzepatide for T2DM treatment

The UK’s National Institute for Health and Care Excellence (NICE) has not recommended tirzepatide (Mounjaro, developed by Eli Lilly) in...

ReShape submits PMA to FDA for next-generation lap-band 2.0

ReShape Lifesciences has submitted a Premarket Approval (PMA) supplement application to the FDA for the company’s next generation,...

Allurion and Medtronic to expand access to AI-powered weight loss programme

Allurion has entered a pilot collaboration agreement with Medtronic, to expand access to Allurion’s AI-powered weight loss programme...

Journal Watch 18/12/2024

2 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

3 hours ago

Obesity-related brain changes can be reversed after bariatric surgery

4 hours ago

Weekly Digest